Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 02, 2023	Apr. 03, 2022
Sales by segment of business
Sales to customers	$ 24,746	$ 23,426
Percent Change (as a percent)	5.60%
U.S.
Sales by segment of business
Sales to customers	$ 12,517	11,414
Percent Change (as a percent)	9.70%
International
Sales by segment of business
Sales to customers	$ 12,229	12,012
Percent Change (as a percent)	1.80%
CONSUMER HEALTH
Sales by segment of business
Sales to customers	$ 3,852	3,586
Percent Change (as a percent)	7.40%
CONSUMER HEALTH | U.S.
Sales by segment of business
Sales to customers	$ 1,735	1,557
Percent Change (as a percent)	11.40%
CONSUMER HEALTH | International
Sales by segment of business
Sales to customers	$ 2,117	2,029
Percent Change (as a percent)	4.40%
CONSUMER HEALTH | OTC [Member]
Sales by segment of business
Sales to customers	$ 1,642	1,461
Percent Change (as a percent)	12.40%
CONSUMER HEALTH | OTC [Member] | U.S.
Sales by segment of business
Sales to customers	$ 745	670
Percent Change (as a percent)	11.00%
CONSUMER HEALTH | OTC [Member] | International
Sales by segment of business
Sales to customers	$ 897	791
Percent Change (as a percent)	13.50%
CONSUMER HEALTH | Skin Health/Beauty
Sales by segment of business
Sales to customers	$ 1,110	1,012
Percent Change (as a percent)	9.70%
CONSUMER HEALTH | Skin Health/Beauty | U.S.
Sales by segment of business
Sales to customers	$ 617	544
Percent Change (as a percent)	13.40%
CONSUMER HEALTH | Skin Health/Beauty | International
Sales by segment of business
Sales to customers	$ 493	468
Percent Change (as a percent)	5.30%
CONSUMER HEALTH | Oral Care
Sales by segment of business
Sales to customers	$ 361	366
Percent Change (as a percent)	(1.30%)
CONSUMER HEALTH | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 159	143
Percent Change (as a percent)	11.60%
CONSUMER HEALTH | Oral Care | International
Sales by segment of business
Sales to customers	$ 202	223
Percent Change (as a percent)	(9.60%)
CONSUMER HEALTH | Baby Care
Sales by segment of business
Sales to customers	$ 359	355
Percent Change (as a percent)	1.00%
CONSUMER HEALTH | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 96	85
Percent Change (as a percent)	13.00%
CONSUMER HEALTH | Baby Care | International
Sales by segment of business
Sales to customers	$ 263	270
Percent Change (as a percent)	(2.80%)
CONSUMER HEALTH | Women’s Health
Sales by segment of business
Sales to customers	$ 217	228
Percent Change (as a percent)	(4.80%)
CONSUMER HEALTH | Women’s Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3
Percent Change (as a percent)	1.80%
CONSUMER HEALTH | Women’s Health | International
Sales by segment of business
Sales to customers	$ 214	224
Percent Change (as a percent)	(4.90%)
CONSUMER HEALTH | Wound Care/Other
Sales by segment of business
Sales to customers	$ 164	164
Percent Change (as a percent)	(0.10%)
CONSUMER HEALTH | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 115	112
Percent Change (as a percent)	2.60%
CONSUMER HEALTH | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 49	52
Percent Change (as a percent)	(6.00%)
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 13,413	12,869
Percent Change (as a percent)	4.20%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 7,023	6,632
Percent Change (as a percent)	5.90%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 6,390	6,237
Percent Change (as a percent)	2.40%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 4,112	4,119
Percent Change (as a percent)	(0.20%)
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,448	2,501
Percent Change (as a percent)	(2.10%)
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 1,664	1,617
Percent Change (as a percent)	2.90%
PHARMACEUTICAL | Immunology | REMICADE
Sales by segment of business
Sales to customers	$ 487	663
Percent Change (as a percent)	(26.50%)
PHARMACEUTICAL | Immunology | REMICADE | U.S.
Sales by segment of business
Sales to customers	$ 276	358
Percent Change (as a percent)	(22.80%)
PHARMACEUTICAL | Immunology | REMICADE | U.S. Exports
Sales by segment of business
Sales to customers	$ 41	80
Percent Change (as a percent)	(48.80%)
PHARMACEUTICAL | Immunology | REMICADE | International
Sales by segment of business
Sales to customers	$ 170	225
Percent Change (as a percent)	(24.40%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA
Sales by segment of business
Sales to customers	$ 537	571
Percent Change (as a percent)	(5.80%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA | U.S.
Sales by segment of business
Sales to customers	$ 271	287
Percent Change (as a percent)	(5.60%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA | International
Sales by segment of business
Sales to customers	$ 266	283
Percent Change (as a percent)	(6.10%)
PHARMACEUTICAL | Immunology | STELARA
Sales by segment of business
Sales to customers	$ 2,444	2,288
Percent Change (as a percent)	6.80%
PHARMACEUTICAL | Immunology | STELARA | U.S.
Sales by segment of business
Sales to customers	$ 1,451	1,379
Percent Change (as a percent)	5.20%
PHARMACEUTICAL | Immunology | STELARA | International
Sales by segment of business
Sales to customers	$ 993	909
Percent Change (as a percent)	9.30%
PHARMACEUTICAL | Immunology | TREMFYA
Sales by segment of business
Sales to customers	$ 640	590
Percent Change (as a percent)	8.40%
PHARMACEUTICAL | Immunology | TREMFYA | U.S.
Sales by segment of business
Sales to customers	$ 406	391
Percent Change (as a percent)	3.90%
PHARMACEUTICAL | Immunology | TREMFYA | International
Sales by segment of business
Sales to customers	$ 234	199
Percent Change (as a percent)	17.30%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 3	6
Percent Change (as a percent)	(51.30%)
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 3	6
Percent Change (as a percent)	(51.20%)
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 0	0
Percent Change (as a percent)	0.00%
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 1,586	1,297
Percent Change (as a percent)	22.30%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 392	461
Percent Change (as a percent)	(14.90%)
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 1,193	836
Percent Change (as a percent)	42.80%
PHARMACEUTICAL | Infectious Diseases | COVID-19
Sales by segment of business
Sales to customers	$ 747	457
Percent Change (as a percent)	63.40%
PHARMACEUTICAL | Infectious Diseases | COVID-19 | U.S.
Sales by segment of business
Sales to customers	$ 0	75
PHARMACEUTICAL | Infectious Diseases | COVID-19 | International
Sales by segment of business
Sales to customers	$ 747	382
Percent Change (as a percent)	95.60%
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine
Sales by segment of business
Sales to customers	$ 280	248
Percent Change (as a percent)	12.80%
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 9	9
Percent Change (as a percent)	(1.40%)
PHARMACEUTICAL | Infectious Diseases | EDURANT / rilpivirine | International
Sales by segment of business
Sales to customers	$ 271	239
Percent Change (as a percent)	13.40%
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA
Sales by segment of business
Sales to customers	$ 477	501
Percent Change (as a percent)	(4.80%)
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.
Sales by segment of business
Sales to customers	$ 378	369
Percent Change (as a percent)	2.50%
PHARMACEUTICAL | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International
Sales by segment of business
Sales to customers	$ 99	132
Percent Change (as a percent)	(25.20%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES(
Sales by segment of business
Sales to customers	$ 82	91
Percent Change (as a percent)	(9.80%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.
Sales by segment of business
Sales to customers	$ 5	8
Percent Change (as a percent)	(33.10%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International
Sales by segment of business
Sales to customers	$ 77	83
Percent Change (as a percent)	(7.60%)
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,804	1,741
Percent Change (as a percent)	3.60%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 978	843
Percent Change (as a percent)	16.00%
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 826	898
Percent Change (as a percent)	(8.10%)
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate
Sales by segment of business
Sales to customers	$ 206	157
Percent Change (as a percent)	31.40%
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 70	35
PHARMACEUTICAL | Neuroscience | CONCERTA / methylphenidate | International
Sales by segment of business
Sales to customers	$ 136	122
Percent Change (as a percent)	11.40%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA
Sales by segment of business
Sales to customers	$ 1,044	1,048
Percent Change (as a percent)	(0.40%)
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.
Sales by segment of business
Sales to customers	$ 713	661
Percent Change (as a percent)	7.90%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International
Sales by segment of business
Sales to customers	$ 331	387
Percent Change (as a percent)	(14.60%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 423	467
Percent Change (as a percent)	(9.40%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 84	86
Percent Change (as a percent)	(3.50%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 339	380
Percent Change (as a percent)	(10.70%)
PHARMACEUTICAL | Neuroscience | SPRAVATO
Sales by segment of business
Sales to customers	$ 131	70
Percent Change (as a percent)	86.90%
PHARMACEUTICAL | Neuroscience | SPRAVATO | U.S.
Sales by segment of business
Sales to customers	$ 111	61
Percent Change (as a percent)	82.40%
PHARMACEUTICAL | Neuroscience | SPRAVATO | International
Sales by segment of business
Sales to customers	$ 20	9
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 4,112	3,950
Percent Change (as a percent)	4.10%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,889	1,582
Percent Change (as a percent)	19.40%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 2,223	2,369
Percent Change (as a percent)	(6.10%)
PHARMACEUTICAL | Oncology | DARZALEX
Sales by segment of business
Sales to customers	$ 2,264	1,856
Percent Change (as a percent)	22.00%
PHARMACEUTICAL | Oncology | DARZALEX | U.S.
Sales by segment of business
Sales to customers	$ 1,191	953
Percent Change (as a percent)	25.00%
PHARMACEUTICAL | Oncology | DARZALEX | International
Sales by segment of business
Sales to customers	$ 1,072	903
Percent Change (as a percent)	18.80%
PHARMACEUTICAL | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 542	400
Percent Change (as a percent)	35.60%
PHARMACEUTICAL | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	$ 249	206
Percent Change (as a percent)	21.20%
PHARMACEUTICAL | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	$ 293	194
Percent Change (as a percent)	50.90%
PHARMACEUTICAL | Oncology | IMBRUVICA
Sales by segment of business
Sales to customers	$ 827	1,038
Percent Change (as a percent)	(20.30%)
PHARMACEUTICAL | Oncology | IMBRUVICA | U.S.
Sales by segment of business
Sales to customers	$ 270	370
Percent Change (as a percent)	(27.10%)
PHARMACEUTICAL | Oncology | IMBRUVICA | International
Sales by segment of business
Sales to customers	$ 557	668
Percent Change (as a percent)	(16.60%)
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate
Sales by segment of business
Sales to customers	$ 245	539
Percent Change (as a percent)	(54.50%)
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 16	19
Percent Change (as a percent)	(14.00%)
PHARMACEUTICAL | Oncology | ZYTIGA / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 229	520
Percent Change (as a percent)	(56.00%)
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 162	118
Percent Change (as a percent)	37.40%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 92	34
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 70	84
Percent Change (as a percent)	(17.20%)
PHARMACEUTICAL | Oncology | CARVYKTI
Sales by segment of business
Sales to customers	$ 72	0
PHARMACEUTICAL | Oncology | CARVYKTI | U.S.
Sales by segment of business
Sales to customers	70	0
PHARMACEUTICAL | Oncology | CARVYKTI | International
Sales by segment of business
Sales to customers	2	0
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 872	852
Percent Change (as a percent)	2.40%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 600	572
Percent Change (as a percent)	4.90%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 272	279
Percent Change (as a percent)	(2.70%)
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT
Sales by segment of business
Sales to customers	$ 440	443
Percent Change (as a percent)	(0.70%)
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT | U.S.
Sales by segment of business
Sales to customers	$ 273	273
Percent Change (as a percent)	(0.10%)
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT | International
Sales by segment of business
Sales to customers	$ 167	170
Percent Change (as a percent)	(1.60%)
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI
Sales by segment of business
Sales to customers	$ 362	325
Percent Change (as a percent)	11.40%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI | U.S.
Sales by segment of business
Sales to customers	$ 304	269
Percent Change (as a percent)	13.10%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI | International
Sales by segment of business
Sales to customers	$ 58	56
Percent Change (as a percent)	3.30%
PHARMACEUTICAL | Pulmonary Hypertension | Other
Sales by segment of business
Sales to customers	$ 70	83
Percent Change (as a percent)	(16.10%)
PHARMACEUTICAL | Pulmonary Hypertension | Other | U.S.
Sales by segment of business
Sales to customers	$ 23	30
Percent Change (as a percent)	(22.40%)
PHARMACEUTICAL | Pulmonary Hypertension | Other | International
Sales by segment of business
Sales to customers	$ 47	53
Percent Change (as a percent)	(12.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 927	910
Percent Change (as a percent)	1.80%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 715	672
Percent Change (as a percent)	6.30%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 212	238
Percent Change (as a percent)	(10.80%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO
Sales by segment of business
Sales to customers	$ 578	508
Percent Change (as a percent)	13.70%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO | U.S.
Sales by segment of business
Sales to customers	$ 578	508
Percent Change (as a percent)	13.70%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO | International
Sales by segment of business
Sales to customers	$ 0	0
Percent Change (as a percent)	0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other
Sales by segment of business
Sales to customers	$ 349	402
Percent Change (as a percent)	(13.20%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | U.S.
Sales by segment of business
Sales to customers	$ 137	164
Percent Change (as a percent)	(16.70%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | International
Sales by segment of business
Sales to customers	$ 212	238
Percent Change (as a percent)	(10.80%)
MEDTECH
Sales by segment of business
Sales to customers	$ 7,481	6,971
Percent Change (as a percent)	7.30%
MEDTECH | U.S.
Sales by segment of business
Sales to customers	$ 3,759	3,225
Percent Change (as a percent)	16.60%
MEDTECH | International
Sales by segment of business
Sales to customers	$ 3,722	3,746
Percent Change (as a percent)	(0.60%)
MEDTECH | Interventional Solutions
Sales by segment of business
Sales to customers	$ 1,503	1,092
Percent Change (as a percent)	37.60%
MEDTECH | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 863	494
Percent Change (as a percent)	74.50%
MEDTECH | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 640	597
Percent Change (as a percent)	7.10%
MEDTECH | ELECTROPHYSIOLOGY
Sales by segment of business
Sales to customers	$ 1,092	1,002
Percent Change (as a percent)	9.10%
MEDTECH | ELECTROPHYSIOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 571	470
Percent Change (as a percent)	21.40%
MEDTECH | ELECTROPHYSIOLOGY | International
Sales by segment of business
Sales to customers	$ 522	532
Percent Change (as a percent)	(1.80%)
MEDTECH | ABIOMED(3)
Sales by segment of business
Sales to customers	$ 324	0
MEDTECH | ABIOMED(3) | U.S.
Sales by segment of business
Sales to customers	264	0
MEDTECH | ABIOMED(3) | International
Sales by segment of business
Sales to customers	60	0
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS
Sales by segment of business
Sales to customers	$ 87	90
Percent Change (as a percent)	(3.90%)
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | U.S.
Sales by segment of business
Sales to customers	$ 28	24
Percent Change (as a percent)	17.40%
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | International
Sales by segment of business
Sales to customers	$ 58	65
Percent Change (as a percent)	(11.70%)
MEDTECH | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,245	2,188
Percent Change (as a percent)	2.60%
MEDTECH | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,363	1,289
Percent Change (as a percent)	5.80%
MEDTECH | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 881	899
Percent Change (as a percent)	(2.00%)
MEDTECH | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 390	389
Percent Change (as a percent)	0.40%
MEDTECH | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 241	225
Percent Change (as a percent)	7.30%
MEDTECH | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 149	164
Percent Change (as a percent)	(9.00%)
MEDTECH | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 368	339
Percent Change (as a percent)	8.70%
MEDTECH | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 226	201
Percent Change (as a percent)	12.40%
MEDTECH | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 142	138
Percent Change (as a percent)	3.40%
MEDTECH | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 757	748
Percent Change (as a percent)	1.20%
MEDTECH | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 491	475
Percent Change (as a percent)	3.20%
MEDTECH | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 267	273
Percent Change (as a percent)	(2.40%)
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 729	712
Percent Change (as a percent)	2.40%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 406	387
Percent Change (as a percent)	4.70%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 323	324
Percent Change (as a percent)	(0.30%)
MEDTECH | Surgery
Sales by segment of business
Sales to customers	$ 2,434	2,434
Percent Change (as a percent)	0.00%
MEDTECH | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 975	921
Percent Change (as a percent)	5.90%
MEDTECH | Surgery | International
Sales by segment of business
Sales to customers	$ 1,459	1,513
Percent Change (as a percent)	(3.60%)
MEDTECH | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,118	1,146
Percent Change (as a percent)	(2.50%)
MEDTECH | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 444	417
Percent Change (as a percent)	6.50%
MEDTECH | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 673	729
Percent Change (as a percent)	(7.60%)
MEDTECH | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,316	1,288
Percent Change (as a percent)	2.20%
MEDTECH | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 531	504
Percent Change (as a percent)	5.40%
MEDTECH | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 785	784
Percent Change (as a percent)	0.20%
MEDTECH | Vision
Sales by segment of business
Sales to customers	$ 1,300	1,257
Percent Change (as a percent)	3.40%
MEDTECH | Vision | U.S.
Sales by segment of business
Sales to customers	$ 558	521
Percent Change (as a percent)	7.10%
MEDTECH | Vision | International
Sales by segment of business
Sales to customers	$ 743	736
Percent Change (as a percent)	0.80%
MEDTECH | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 953	910
Percent Change (as a percent)	4.70%
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 444	400
Percent Change (as a percent)	11.10%
MEDTECH | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 509	511
Percent Change (as a percent)	(0.30%)
MEDTECH | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 347	347
Percent Change (as a percent)	0.10%
MEDTECH | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 114	121
Percent Change (as a percent)	(6.00%)
MEDTECH | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 233	$ 226
Percent Change (as a percent)	3.30%